Arthritis Research & Therapy

official impact factor 4.36

Highly Access

Cell therapy for autoimmune diseases

Francesco Dazzi*, Jacob M van Laar, Andrew Cope and Alan Tyndall

Arthritis Research & Therapy 2007, 9:206 doi:10.1186/ar2128

Accesses  

  • Last 30 days: 84 accesses
  • Last 365 days: 872 accesses
  • All time: 5842 accesses

Cited by